The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Myelodysplastic Syndromes: An Evidence-Based Review
Denise M. Oliansky, Joseph H. Antin, John M. Bennett, H. Joachim Deeg, Christin Engelhardt, Kathleen V. Heptinstall, Marcos de Lima, Steven D. Gore, Ronald G. Potts, Lewis R. Silverman, Roy B. Jones, Philip L. McCarthy, Theresa Hahn
Biology of Blood and Marrow Transplantation
February 2009 (Vol. 15, Issue 2, Pages 137-172) Abstract |
Full Text |
Full-Text PDF (648 KB)
In the article entitled “The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Myelodysplastic Syndromes: An Evidence-Based Review” by Oliansky et al., in the February 2009 issue of Biology of Blood and Marrow Transplantation (Volume 15, Number 2, pages 137-172), reference 7 should have been listed as follows:
Jones R, Nieto Y, Rizzo JD, et al. The evolution of the evidence-based review: evaluating the science enhances the art of medicine-Statement of the Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2005;11:819-822.
FULL TEXT